Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2012
05/03/2012WO2012016227A3 Antibodies with modified isoelectric points
05/03/2012WO2012013930A3 Process for purifying proteins
05/03/2012WO2012006437A3 Polypeptides having antiviral activity and methods for use thereof
05/03/2012WO2011163478A3 Dual variable domain immunoglobulins and uses thereof
05/03/2012WO2011161226A3 Novel antibody formulation
05/03/2012WO2011120013A3 Vista regulatory t cell mediator protein, vista binding agents and use thereof
05/03/2012WO2011041336A3 Treating notch1-antagonist-resistant cancer (s) using notch3 antagonists
05/03/2012US20120109097 Recombinant il-9 antibodies and uses thereof
05/03/2012US20120108880 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
05/03/2012US20120108797 Targeted binding agents directed to upar and uses thereof
05/03/2012US20120108796 Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI)
05/03/2012US20120108795 Antibodies Binding Human Collagen II
05/03/2012US20120108794 Formyl Group-Containing Porous Support, Adsorbent Using Same, Method For Producing Same, and Method For Producing The Adsorbent
05/03/2012US20120108662 Compositions and methods for treating skin disorders
05/03/2012US20120108657 Disease-associated protein
05/03/2012US20120108523 Disease-associated protein
05/03/2012US20120108493 Polypeptide Fragments Comprising Endonuclease Activity and Their Use
05/03/2012US20120107933 Anti-mesothelin antibodies
05/03/2012US20120107932 Prrs-virus receptor and its inhibitor
05/03/2012US20120107928 Antibody Inhibitors of GDF-8 and Uses Thereof
05/03/2012US20120107874 Modified Host Cells and Uses Thereof
05/03/2012US20120107858 Cancer diagnosis method using the glycosylation of a glycoprotein
05/03/2012US20120107848 Polyclonal-monoclonal elisa assay for detecting n-terminus pro-bnp
05/03/2012US20120107841 Serum Diagnostic Method, Biomarker and Kit for Early Detection and Staging of Alzheimer's Disease
05/03/2012US20120107833 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
05/03/2012US20120107364 Antibody having anti-cancer activity
05/03/2012US20120107362 Neurotoxins exhibiting shortened biological activity
05/03/2012US20120107357 Novel divergent picornavirus: cosavirus
05/03/2012US20120107342 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method
05/03/2012US20120107335 Synthetic Oligopeptides Designed From Mite Cysteine Proteases and Methods for the Production of
05/03/2012US20120107333 Vangl1 peptides and vaccines including the same
05/03/2012US20120107330 Antagonists, uses & methods for partially inhibiting tnfr1
05/03/2012US20120107325 IL-17 Antagonistic Antibodies
05/03/2012US20120107324 TARGETED BINDING AGENTS DIRECTED TO a5ß1 AND USES THEREOF
05/03/2012US20120107322 Immunogenic and therapeutic compositions for streptococcus pyogenes
05/03/2012US20120107321 Antibodies And Epitopes Specific To Misfolded Prion Protein
05/03/2012US20120107320 Antibodies specifically directed to the soluble form of ctla-4
05/03/2012US20120107319 Pharmaceutical compositions comprising antibodies binding to the intracellular domain of EBV (Epstein-Barr virus) latent membrane protein-1 (LMP1)
05/03/2012US20120107318 Methods of administering pif agonist peptides and uses thereof
05/03/2012US20120107316 Protective anti-glucan antibodies with preference for beta-1,3-glucans
05/03/2012US20120107314 Cab molecules
05/03/2012US20120107313 Mammalian receptor proteins; related reagents and methods
05/03/2012US20120107306 Antibodies for epidermal growth factor receptor 3 (her3)
05/03/2012US20120107301 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
05/03/2012US20120107299 Phosphorylation-inhibiting agent or dephosphorylating agent for pten
05/03/2012US20120107243 Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier
05/03/2012US20120107235 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof
05/03/2012US20120107233 Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
05/03/2012CA2819117A1 Anti-sod1 antibodies and uses thereof
05/03/2012CA2816291A1 Novel anti-dr5 antibody
05/03/2012CA2816225A1 Antibodies which bind soluble t-cell receptor ligands
05/03/2012CA2815888A1 Clostridium difficile-specific antibodies and uses thereof
05/03/2012CA2815277A1 Novel egfr-binding molecules and immunoconjugates thereof
05/03/2012CA2815267A1 Spider silk fusion protein structures for binding to an organic target
05/03/2012CA2815181A1 Dkk1 antibodies and methods of use
05/03/2012CA2815119A1 Means and methods for treating dlbcl
05/03/2012CA2814908A1 Antibodies for the treatment of hiv
05/02/2012EP2447372A2 Anti alpha v beta 6 antibodies and uses thereof
05/02/2012EP2447369A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447368A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447367A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447284A1 Anti-idiotypic antibodies neutralising the inhibiting activity of an inhibiting antibody directed against domain C1 of factor VIII
05/02/2012EP2447283A2 Human monoclonal antibodies to activin receptor-like kinase-1 (ALK-1)
05/02/2012EP2447282A2 Anti-CD22 Antibodies, their Immunoconjugates and uses thereof
05/02/2012EP2447281A1 Novel anti-PLGF antibody
05/02/2012EP2447278A1 Novel immunogenic proteins of Leptospira
05/02/2012EP2446904A2 Anti-CD22 antibodies, their immunoconjugates and uses thereof
05/02/2012EP2446902A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446901A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446900A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446897A1 Anti-KIR combination treatments and methods
05/02/2012EP2446890A1 High viscosity macromolecular compositions for treating ocular conditions
05/02/2012EP2446038A1 Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin
05/02/2012EP2445937A1 Bispecific antibodies that bind to complement proteins
05/02/2012EP2445936A1 Readily isolated bispecific antibodies with native immunoglobulin format
05/02/2012EP2445925A1 Protein purification by caprylic acid (octanoic acid) precipitation
05/02/2012EP2445530A1 Method for treating chronic lymphocytic leukemia
05/02/2012EP2445528A1 Method of treating cancer with dll4 antagonist and chemotherapeutic agent
05/02/2012EP2445482A1 Method for preparing an enriched igg composition from plasma
05/02/2012EP1727563B1 Method for amplifying therapeutic vaccine activity
05/02/2012EP1634951B1 Novel protein
05/02/2012EP1597280B1 Monoclonal antibody production by ebv transformation of b cells
05/02/2012EP1511391B1 Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration
05/02/2012EP1343822B1 Means for the diagnosis and therapy of ctcl
05/02/2012EP1256348B1 Remedies for hepatitis c
05/02/2012CN102439147A Vangl1 peptides and vaccines including the same
05/02/2012CN102439042A Method for assaying prodefensin-a6 for the in vitro diagnosis of colorectal cancer
05/02/2012CN102439041A Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders
05/02/2012CN102439040A Anti-tnf-a antibodies and their uses
05/02/2012CN102439039A Treatment for multiple sclerosis
05/02/2012CN102439038A Antibody
05/02/2012CN102439036A Bispecific egfr/igfir binding molecules
05/02/2012CN102439035A Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions
05/02/2012CN102438702A Anti-mst1r antibodies and uses thereof
05/02/2012CN102438653A Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue and/or fever
05/02/2012CN102438652A Antibody formulation
05/02/2012CN102435742A Application of monoclonal antibody for Riemerella anatipestifer in preparation of immune colloidal gold test paper
05/02/2012CN102432685A Immune latex microspheres for detecting recombined mouse basic fibroblast growth factor and preparation method and application of immune latex microspheres
05/02/2012CN102432684A Preparation method and application of clenbuterol monoclonal antibody
05/02/2012CN102432683A Preparation of multi-epitope TK1 antibody and application of multi-epitope TK1 antibody to evaluation on recurrence risk and prognosis of tumor patient at early stage
1 ... 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 ... 1494